RAC 1.11% $1.83 race oncology ltd

Ann: FDA RPD Designation Granted for RC220 Bisantrene, page-58

  1. 1,395 Posts.
    lightbulb Created with Sketch. 444
    Yea I get that.

    But the initial NDA application needs to for either:

    Paediatric AML
    Paediatric and adult AML

    If approved in adults only, initially, then PRV is off the table even if approved for Paediatric AML further down the track.

    That's how it reads and how I've understood it. Would be happy to be corrected as I hold several other RPDD biotechs.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.